Patent · US Active

Opiate reduction utilizing catalytic hydrogen transfer reaction

US8309727B2 · kind B2 · utility

10Cited by
23References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 15, 2008
Grant dateNov 13, 2012
Priority date
Expiry dateJul 29, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D489/02
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

An improved opiate synthesis scheme is provided. An improvement to the oxidation of oripavine and oripavine derivatives comprises the in-situ formation of the peroxacids required to oxidize the oripavine and oripavine derivatives to form an intermediate. An improvement to the reduction of the intermediate to form oxycodone and oxycodone derivatives comprises reduction utilizing a hydrogen transfer reagent. These improvements allow the production of oxycodone and oxycodone derivatives without isolation of the intermediate, providing a one-pot synthesis method.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.